9 insiders reported 34 Form 4 transactions for Akoya Biosciences, Inc. (AKYA) over the past 18 months (most recent 2025-07-10). Recent activity: BAMFORD PASCAL (Chief Clinical Officer) Sell 9,488 shares, Kamocsay Jennifer (Chief Legal Officer) Sell 162,500 shares, Raffin Thomas A. (Director) Sell 15.9M shares, Ramachandran Niro Ph.D (Chief Business Officer) Buy 62,566 shares, Ramachandran Niro Ph.D (Chief Business Officer) Sell 42,148 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-07-10 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 9,488 | $0 |
| 2025-07-10 | Kamocsay Jennifer | Chief Legal Officer | Sell | 162,500 | $0 |
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 15.9M | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Buy | 62,566 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 42,148 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 151,930 | $0 |
| 2025-07-10 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 130,625 | $0 |
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 1.7M | $0 |
| 2025-07-10 | Mendel Scott | Director | Sell | 28,500 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Buy | 393,338 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Buy | 331,090 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Sell | 196,866 | $0 |
| 2025-07-10 | McKelligon Brian | President and CEO | Sell | 947,688 | $0 |
| 2025-07-10 | Raffin Thomas A. | Director | Sell | 234,592 | $0 |
| 2025-07-10 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 196,250 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 54,452 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 193,750 | $0 |
| 2025-07-10 | Ek John Frederick | CFO | Sell | 20,000 | $0 |
| 2025-07-10 | LAI GOLDMAN MYLA | Director | Sell | 20,000 | $0 |
| 2025-07-10 | Kamocsay Jennifer | Chief Legal Officer | Sell | 16,772 | $0 |
| 2025-07-10 | Winkler Matthew | Director | Sell | 984,513 | $0 |
| 2025-06-02 | BAMFORD PASCAL | Chief Clinical Officer | Sell | 670 | $838 |
| 2025-04-03 | Ek John Frederick | CFO | Sell | 16,432 | $22,183 |
| 2025-03-25 | McKelligon Brian | President and CEO | Sell | 7,550 | $12,835 |
| 2025-03-25 | Ramachandran Niro Ph.D | Chief Business Officer | Sell | 2,310 | $3,927 |
Source: SEC Form 4 filings · as of 2025-07-10